| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
MAFB |
MAFB, KRML: Transcription factor MafB |
0.347 |
Evidence |
|
| CHRNB2 |
CHRNB2: Neuronal acetylcholine receptor subunit beta-2 precursor |
CHRNA10 |
CHRNA10, NACHRA10: Neuronal acetylcholine receptor subunit alpha-10 precursor |
0.347 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
ATF3 |
ATF3: Cyclic AMP-dependent transcription factor ATF-3 |
0.347 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
0.347 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.347 |
Evidence |
|
| IL1R1 |
IL1R1, IL1R, IL1RA, IL1RT1: Interleukin-1 receptor type I precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.347 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
0.347 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
0.347 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.347 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.347 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
MNT |
MNT, ROX: Max-binding protein MNT |
0.347 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
0.347 |
Evidence |
|
| GZMA |
GZMA, CTLA3, HFSP: Granzyme A precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
TBXA2R |
TBXA2R: TBXA2R protein |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
CYSLTR1 |
CYSLT1, CYSLTR1: Cysteinyl leukotriene receptor 1 |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
NPY2R |
NPY2R: Neuropeptide Y receptor type 2 |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
HTR2B |
HTR2B: 5-hydroxytryptamine receptor 2B |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
BRS3 |
BRS3: Bombesin receptor subtype-3 |
0.347 |
Evidence |
|
| HSPA5 |
HSPA5: HSPA5 protein |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.347 |
Evidence |
|
| TXN |
TXN, TRDX, TRX, TRX1: Thioredoxin |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.347 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.347 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.347 |
Evidence |
|
| WNT2 |
WNT2, INT1L1, IRP: Protein Wnt-2 precursor |
FRZB |
FRZB, FIZ, FRE, FRP, FRZB1, SFRP3: Secreted frizzled-related protein 3 precursor |
0.347 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GPR132 |
GPR132, G2A: Probable G-protein coupled receptor 132 |
0.347 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.347 |
Evidence |
|